Furthermore, our previous analysis found that pretreatment HLA‐B*59:01 screening for clozapine was cost‐effective and beneficial for reducing the incidences of neutropenia and agranulocytosis in the Japanese population.24 This evidence concerns the gene HLA-B and Absence of circulating granulocytes.